BIOMAT Database Logo BIOMAT Database Logo

[Treatment of arterial hypertension with guanethidine, 1-alpha-methyldopa and pargyline hydrochloride]. 1966

F Montoreano, and H Abrahim, and J Plotquin

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008750 Methyldopa An alpha-2 adrenergic agonist that has both central and peripheral nervous system effects. Its primary clinical use is as an antihypertensive agent. Methyldopate,alpha-Methyldopa,Aldomet,Alphamethyldopa,Apo-Methyldopa,Dopamet,Dopegit,Dopegyt,Dopergit,Hydopa,Meldopa,Nu-Medopa,Sembrina,alpha-Methyl-L-Dopa,Apo Methyldopa,Nu Medopa,alpha Methyl L Dopa,alpha Methyldopa
D010293 Pargyline A monoamine oxidase inhibitor with antihypertensive properties. Pargyline Hydrochloride,Hydrochloride, Pargyline
D006145 Guanethidine An antihypertensive agent that acts by inhibiting selectively transmission in post-ganglionic adrenergic nerves. It is believed to act mainly by preventing the release of norepinephrine at nerve endings and causes depletion of norepinephrine in peripheral sympathetic nerve terminals as well as in tissues. ((2-Hexahydro-1(2H)-azocinyl)ethyl)guanidine,Guanethidine Monosulfate,Guanethidine Sulfate,Guanethidine Sulfate (1:1),Guanethidine Sulfate (1:2),Guanethidine Sulfate (2:1),Guanethidine Sulfate (2:1), 14C-Labeled,Ismelin,Isobarin,Octadine,Oktadin,Monosulfate, Guanethidine,Sulfate, Guanethidine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

F Montoreano, and H Abrahim, and J Plotquin
[Treatment of arterial hypertension with pargyline hydrochloride].
December 1966, Semaine therapeutique,
F Montoreano, and H Abrahim, and J Plotquin
[Pargyline hydrochloride in the treatment of arterial hypertension].
October 1965, Revista medica de Chile,
F Montoreano, and H Abrahim, and J Plotquin
[Treatment of arterial hypertension with alpha-methyldopa].
September 1969, Medicina interna,
F Montoreano, and H Abrahim, and J Plotquin
Moderate hypertension: treatment with guanethidine and methyldopa.
August 1975, Current therapeutic research, clinical and experimental,
F Montoreano, and H Abrahim, and J Plotquin
Treatment of hypertension with pargyline hydrochloride.
July 1966, Current therapeutic research, clinical and experimental,
F Montoreano, and H Abrahim, and J Plotquin
[ALPHA-METHYLDOPA IN TREATMENT OF ARTERIAL HYPERTENSION].
February 1965, Minerva medica,
F Montoreano, and H Abrahim, and J Plotquin
[Clinical experience using pargyline hydrochloride in the treatment of arterial hypertension].
April 1968, Revista clinica espanola,
F Montoreano, and H Abrahim, and J Plotquin
The relative efficacy of guanethidine, methyldopa and pargyline as antihypertensive agents.
September 1965, The New England journal of medicine,
F Montoreano, and H Abrahim, and J Plotquin
[Pargyline hydrochloride and hypertension].
March 1966, Revista medica de Chile,
F Montoreano, and H Abrahim, and J Plotquin
[Treatment of arterial hypertension with an alpha-methyldopa-hydrochlorothiazide combination].
June 1966, La Presse medicale,
Copied contents to your clipboard!